Yes, I'm sure it is.
Anyway, we're assembled here today to do clause-by-clause consideration of Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts. It has a lot of clauses, and we have some experts with us at the table to help us through. I'll introduce them.
We have Kirsten Mattison, director of controlled substances directorate, healthy environments and consumer safety branch of the Department of Health, and Miriam Brouillet, legal counsel, Health Canada legal services. Welcome.
From Canada Border Services Agency, we have Megan Imrie, director general, commercial program directorate, and Cathy Toxopeus, director of program performance and reporting division. Thanks very much for coming, and we'll be calling on you from time to time.
We have legal counsel and a lot of advice to help us through this clause-by-clause study. Is everybody ready? All right.
We've had no amendments proposed—
Yes, Mr. Davies.